Free Trial

Relmada Therapeutics (RLMD) SEC Filings & 10K Form

Relmada Therapeutics logo
$2.80 +0.05 (+1.82%)
(As of 11/22/2024 ET)

Recent Relmada Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
8:41 AM
Deep Track Capital, LP (Filed by)
Relmada Therapeutics (Subject)
Form SC 13G/A
10/23/2024
3:27 PM
CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
11:15 PM
Relmada Therapeutics (Filer)
Form EFFECT
09/11/2024
4:46 PM
Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:46 PM
Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:47 PM
CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:47 PM
Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:23 PM
Relmada Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/29/2024
8:23 PM
CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:23 PM
Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:24 PM
Fedeli Fabiana (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:24 PM
GLASSPOOL JOHN (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:24 PM
Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:24 PM
Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:25 PM
Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:10 PM
Relmada Therapeutics (Filer)
Form DEF 14A
04/09/2024
3:15 PM
Relmada Therapeutics (Filer)
Form DEFA14A
03/06/2024
3:15 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Relmada Therapeutics (Subject)
Form SC 13G/A
02/14/2024
7:53 AM
Deep Track Capital, LP (Filed by)
Relmada Therapeutics (Subject)
Form SC 13G/A
02/14/2024
6:49 AM
Relmada Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2024
4:13 PM
Relmada Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/31/2024
5:28 PM
Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
5:28 PM
Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
5:29 PM
Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:30 PM
Relmada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:11 AM
Relmada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
4:27 PM
Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:27 PM
Fedeli Fabiana (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:27 PM
GLASSPOOL JOHN (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:28 PM
Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:28 PM
Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:28 PM
Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:26 PM
CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RLMD) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners